nodes	percent_of_prediction	percent_of_DWPC	metapath
Aminoglutethimide—CYP19A1—prostate cancer	0.185	0.453	CbGaD
Aminoglutethimide—CYP2C19—prostate cancer	0.137	0.334	CbGaD
Aminoglutethimide—CYP3A4—prostate cancer	0.0868	0.213	CbGaD
Aminoglutethimide—CYP2C19—Nilutamide—prostate cancer	0.0376	0.0987	CbGbCtD
Aminoglutethimide—CYP2C19—Bicalutamide—prostate cancer	0.0376	0.0987	CbGbCtD
Aminoglutethimide—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0346	0.0909	CbGbCtD
Aminoglutethimide—CYP2C19—Flutamide—prostate cancer	0.0312	0.0818	CbGbCtD
Aminoglutethimide—CYP1A2—Flutamide—prostate cancer	0.0288	0.0755	CbGbCtD
Aminoglutethimide—CYP1A2—Estrone—prostate cancer	0.0208	0.0546	CbGbCtD
Aminoglutethimide—CYP3A4—Bicalutamide—prostate cancer	0.0182	0.0477	CbGbCtD
Aminoglutethimide—CYP3A4—Estramustine—prostate cancer	0.0169	0.0444	CbGbCtD
Aminoglutethimide—CYP3A4—Flutamide—prostate cancer	0.0151	0.0396	CbGbCtD
Aminoglutethimide—CYP3A4—Abiraterone—prostate cancer	0.0151	0.0396	CbGbCtD
Aminoglutethimide—CYP1A2—Conjugated Estrogens—prostate cancer	0.0136	0.0357	CbGbCtD
Aminoglutethimide—CYP2C19—Estradiol—prostate cancer	0.0129	0.034	CbGbCtD
Aminoglutethimide—CYP1A2—Estradiol—prostate cancer	0.0119	0.0314	CbGbCtD
Aminoglutethimide—CYP3A4—Cabazitaxel—prostate cancer	0.0112	0.0293	CbGbCtD
Aminoglutethimide—CYP2C19—Prednisone—prostate cancer	0.0111	0.0292	CbGbCtD
Aminoglutethimide—CYP3A4—Estrone—prostate cancer	0.0109	0.0286	CbGbCtD
Aminoglutethimide—CYP3A4—Ethinyl Estradiol—prostate cancer	0.00971	0.0255	CbGbCtD
Aminoglutethimide—CYP1A2—Etoposide—prostate cancer	0.0078	0.0205	CbGbCtD
Aminoglutethimide—CYP3A4—Conjugated Estrogens—prostate cancer	0.00713	0.0187	CbGbCtD
Aminoglutethimide—CYP3A4—Mitoxantrone—prostate cancer	0.00648	0.017	CbGbCtD
Aminoglutethimide—CYP3A4—Estradiol—prostate cancer	0.00626	0.0164	CbGbCtD
Aminoglutethimide—CYP3A4—Prednisone—prostate cancer	0.00538	0.0141	CbGbCtD
Aminoglutethimide—CYP19A1—semen—prostate cancer	0.00425	0.302	CbGeAlD
Aminoglutethimide—CYP3A4—Etoposide—prostate cancer	0.00409	0.0107	CbGbCtD
Aminoglutethimide—CYP3A4—Docetaxel—prostate cancer	0.00374	0.00981	CbGbCtD
Aminoglutethimide—CYP3A4—Doxorubicin—prostate cancer	0.00279	0.00731	CbGbCtD
Aminoglutethimide—CYP2C19—urine—prostate cancer	0.00243	0.173	CbGeAlD
Aminoglutethimide—CYP1A2—urine—prostate cancer	0.00199	0.141	CbGeAlD
Aminoglutethimide—CYP3A4—urine—prostate cancer	0.00144	0.102	CbGeAlD
Aminoglutethimide—CYP19A1—prostate gland—prostate cancer	0.00106	0.0757	CbGeAlD
Aminoglutethimide—CYP11A1—testis—prostate cancer	0.000722	0.0513	CbGeAlD
Aminoglutethimide—CYP11A1—lymph node—prostate cancer	0.000523	0.0372	CbGeAlD
Aminoglutethimide—CYP1A2—renal system—prostate cancer	0.000486	0.0346	CbGeAlD
Aminoglutethimide—CYP19A1—testis—prostate cancer	0.000469	0.0333	CbGeAlD
Aminoglutethimide—CYP3A4—renal system—prostate cancer	0.000352	0.025	CbGeAlD
Aminoglutethimide—CYP19A1—lymph node—prostate cancer	0.00034	0.0242	CbGeAlD
Aminoglutethimide—Musculoskeletal discomfort—Bicalutamide—prostate cancer	0.000314	0.00365	CcSEcCtD
Aminoglutethimide—Somnolence—Bicalutamide—prostate cancer	0.000306	0.00356	CcSEcCtD
Aminoglutethimide—Nausea—Estrone—prostate cancer	0.000305	0.00355	CcSEcCtD
Aminoglutethimide—Vomiting—Nilutamide—prostate cancer	0.000303	0.00353	CcSEcCtD
Aminoglutethimide—Vomiting—Flutamide—prostate cancer	0.000302	0.00352	CcSEcCtD
Aminoglutethimide—Pruritus—Degarelix—prostate cancer	0.000302	0.00351	CcSEcCtD
Aminoglutethimide—Rash—Nilutamide—prostate cancer	0.000301	0.0035	CcSEcCtD
Aminoglutethimide—Dermatitis—Nilutamide—prostate cancer	0.000301	0.0035	CcSEcCtD
Aminoglutethimide—Rash—Flutamide—prostate cancer	0.0003	0.00349	CcSEcCtD
Aminoglutethimide—Decreased appetite—Bicalutamide—prostate cancer	0.000299	0.00349	CcSEcCtD
Aminoglutethimide—Dermatitis—Flutamide—prostate cancer	0.000299	0.00348	CcSEcCtD
Aminoglutethimide—Headache—Nilutamide—prostate cancer	0.000299	0.00348	CcSEcCtD
Aminoglutethimide—Headache—Flutamide—prostate cancer	0.000298	0.00346	CcSEcCtD
Aminoglutethimide—Dizziness—Estradiol valerate/Dienogest—prostate cancer	0.000297	0.00345	CcSEcCtD
Aminoglutethimide—Hypersensitivity—Cabazitaxel—prostate cancer	0.000296	0.00344	CcSEcCtD
Aminoglutethimide—Pancytopenia—Mitoxantrone—prostate cancer	0.000296	0.00344	CcSEcCtD
Aminoglutethimide—Neutropenia—Mitoxantrone—prostate cancer	0.000291	0.00339	CcSEcCtD
Aminoglutethimide—Vomiting—Estradiol valerate/Dienogest—prostate cancer	0.000285	0.00332	CcSEcCtD
Aminoglutethimide—Nausea—Nilutamide—prostate cancer	0.000283	0.0033	CcSEcCtD
Aminoglutethimide—Rash—Estradiol valerate/Dienogest—prostate cancer	0.000283	0.00329	CcSEcCtD
Aminoglutethimide—Dermatitis—Estradiol valerate/Dienogest—prostate cancer	0.000282	0.00329	CcSEcCtD
Aminoglutethimide—Nausea—Flutamide—prostate cancer	0.000282	0.00328	CcSEcCtD
Aminoglutethimide—Dizziness—Degarelix—prostate cancer	0.000282	0.00328	CcSEcCtD
Aminoglutethimide—Headache—Estradiol valerate/Dienogest—prostate cancer	0.000281	0.00327	CcSEcCtD
Aminoglutethimide—Drowsiness—Mitoxantrone—prostate cancer	0.000278	0.00323	CcSEcCtD
Aminoglutethimide—Urticaria—Bicalutamide—prostate cancer	0.000274	0.00318	CcSEcCtD
Aminoglutethimide—Body temperature increased—Bicalutamide—prostate cancer	0.000272	0.00317	CcSEcCtD
Aminoglutethimide—Anaemia—Goserelin—prostate cancer	0.000271	0.00316	CcSEcCtD
Aminoglutethimide—Vomiting—Degarelix—prostate cancer	0.000271	0.00315	CcSEcCtD
Aminoglutethimide—Rash—Degarelix—prostate cancer	0.000269	0.00313	CcSEcCtD
Aminoglutethimide—Dermatitis—Degarelix—prostate cancer	0.000269	0.00313	CcSEcCtD
Aminoglutethimide—Headache—Degarelix—prostate cancer	0.000267	0.00311	CcSEcCtD
Aminoglutethimide—Haemolytic anaemia—Capecitabine—prostate cancer	0.000267	0.00311	CcSEcCtD
Aminoglutethimide—Nausea—Estradiol valerate/Dienogest—prostate cancer	0.000266	0.0031	CcSEcCtD
Aminoglutethimide—Dizziness—Cabazitaxel—prostate cancer	0.000266	0.00309	CcSEcCtD
Aminoglutethimide—Leukopenia—Goserelin—prostate cancer	0.000263	0.00306	CcSEcCtD
Aminoglutethimide—Agranulocytosis—Mitoxantrone—prostate cancer	0.000259	0.00301	CcSEcCtD
Aminoglutethimide—Vomiting—Cabazitaxel—prostate cancer	0.000255	0.00297	CcSEcCtD
Aminoglutethimide—Hypersensitivity—Bicalutamide—prostate cancer	0.000254	0.00295	CcSEcCtD
Aminoglutethimide—Nausea—Degarelix—prostate cancer	0.000253	0.00295	CcSEcCtD
Aminoglutethimide—Headache—Cabazitaxel—prostate cancer	0.000252	0.00293	CcSEcCtD
Aminoglutethimide—Myalgia—Goserelin—prostate cancer	0.00025	0.00291	CcSEcCtD
Aminoglutethimide—Myalgia—Conjugated Estrogens—prostate cancer	0.000248	0.00288	CcSEcCtD
Aminoglutethimide—Pancytopenia—Etoposide—prostate cancer	0.000246	0.00286	CcSEcCtD
Aminoglutethimide—Pruritus—Bicalutamide—prostate cancer	0.000244	0.00284	CcSEcCtD
Aminoglutethimide—Neutropenia—Etoposide—prostate cancer	0.000242	0.00282	CcSEcCtD
Aminoglutethimide—Nausea—Cabazitaxel—prostate cancer	0.000239	0.00278	CcSEcCtD
Aminoglutethimide—Tachycardia—Goserelin—prostate cancer	0.000234	0.00272	CcSEcCtD
Aminoglutethimide—Tachycardia—Conjugated Estrogens—prostate cancer	0.000232	0.0027	CcSEcCtD
Aminoglutethimide—Urticaria—Ethinyl Estradiol—prostate cancer	0.000231	0.00269	CcSEcCtD
Aminoglutethimide—Body temperature increased—Ethinyl Estradiol—prostate cancer	0.00023	0.00268	CcSEcCtD
Aminoglutethimide—Anorexia—Goserelin—prostate cancer	0.000228	0.00266	CcSEcCtD
Aminoglutethimide—Dizziness—Bicalutamide—prostate cancer	0.000228	0.00265	CcSEcCtD
Aminoglutethimide—Anorexia—Conjugated Estrogens—prostate cancer	0.000226	0.00263	CcSEcCtD
Aminoglutethimide—Hypotension—Goserelin—prostate cancer	0.000224	0.00261	CcSEcCtD
Aminoglutethimide—Hypotension—Conjugated Estrogens—prostate cancer	0.000222	0.00258	CcSEcCtD
Aminoglutethimide—Vomiting—Bicalutamide—prostate cancer	0.000219	0.00255	CcSEcCtD
Aminoglutethimide—Musculoskeletal discomfort—Goserelin—prostate cancer	0.000218	0.00254	CcSEcCtD
Aminoglutethimide—Rash—Bicalutamide—prostate cancer	0.000217	0.00253	CcSEcCtD
Aminoglutethimide—Dermatitis—Bicalutamide—prostate cancer	0.000217	0.00253	CcSEcCtD
Aminoglutethimide—Musculoskeletal discomfort—Conjugated Estrogens—prostate cancer	0.000216	0.00252	CcSEcCtD
Aminoglutethimide—Headache—Bicalutamide—prostate cancer	0.000216	0.00251	CcSEcCtD
Aminoglutethimide—Agranulocytosis—Etoposide—prostate cancer	0.000215	0.00251	CcSEcCtD
Aminoglutethimide—Hypersensitivity—Ethinyl Estradiol—prostate cancer	0.000215	0.0025	CcSEcCtD
Aminoglutethimide—Somnolence—Goserelin—prostate cancer	0.000213	0.00248	CcSEcCtD
Aminoglutethimide—Somnolence—Conjugated Estrogens—prostate cancer	0.000211	0.00246	CcSEcCtD
Aminoglutethimide—Decreased appetite—Goserelin—prostate cancer	0.000208	0.00242	CcSEcCtD
Aminoglutethimide—Decreased appetite—Conjugated Estrogens—prostate cancer	0.000206	0.0024	CcSEcCtD
Aminoglutethimide—Pruritus—Ethinyl Estradiol—prostate cancer	0.000206	0.0024	CcSEcCtD
Aminoglutethimide—Nausea—Bicalutamide—prostate cancer	0.000205	0.00238	CcSEcCtD
Aminoglutethimide—Pancytopenia—Docetaxel—prostate cancer	0.000204	0.00238	CcSEcCtD
Aminoglutethimide—Neutropenia—Docetaxel—prostate cancer	0.000201	0.00234	CcSEcCtD
Aminoglutethimide—Anaemia—Mitoxantrone—prostate cancer	0.0002	0.00233	CcSEcCtD
Aminoglutethimide—Myalgia—Estradiol—prostate cancer	0.000198	0.00231	CcSEcCtD
Aminoglutethimide—Pancytopenia—Capecitabine—prostate cancer	0.000198	0.0023	CcSEcCtD
Aminoglutethimide—Neutropenia—Capecitabine—prostate cancer	0.000195	0.00227	CcSEcCtD
Aminoglutethimide—Leukopenia—Mitoxantrone—prostate cancer	0.000194	0.00226	CcSEcCtD
Aminoglutethimide—Dizziness—Ethinyl Estradiol—prostate cancer	0.000193	0.00224	CcSEcCtD
Aminoglutethimide—Urticaria—Goserelin—prostate cancer	0.00019	0.00222	CcSEcCtD
Aminoglutethimide—Body temperature increased—Goserelin—prostate cancer	0.000189	0.0022	CcSEcCtD
Aminoglutethimide—Urticaria—Conjugated Estrogens—prostate cancer	0.000189	0.00219	CcSEcCtD
Aminoglutethimide—Body temperature increased—Conjugated Estrogens—prostate cancer	0.000188	0.00218	CcSEcCtD
Aminoglutethimide—Tachycardia—Estradiol—prostate cancer	0.000185	0.00216	CcSEcCtD
Aminoglutethimide—Vomiting—Ethinyl Estradiol—prostate cancer	0.000185	0.00215	CcSEcCtD
Aminoglutethimide—Myalgia—Mitoxantrone—prostate cancer	0.000185	0.00215	CcSEcCtD
Aminoglutethimide—Rash—Ethinyl Estradiol—prostate cancer	0.000184	0.00214	CcSEcCtD
Aminoglutethimide—Dermatitis—Ethinyl Estradiol—prostate cancer	0.000183	0.00213	CcSEcCtD
Aminoglutethimide—Headache—Ethinyl Estradiol—prostate cancer	0.000182	0.00212	CcSEcCtD
Aminoglutethimide—Agranulocytosis—Docetaxel—prostate cancer	0.000179	0.00208	CcSEcCtD
Aminoglutethimide—Hypersensitivity—Goserelin—prostate cancer	0.000177	0.00205	CcSEcCtD
Aminoglutethimide—Hypersensitivity—Conjugated Estrogens—prostate cancer	0.000175	0.00204	CcSEcCtD
Aminoglutethimide—Neutropenia—Prednisone—prostate cancer	0.000174	0.00202	CcSEcCtD
Aminoglutethimide—Agranulocytosis—Capecitabine—prostate cancer	0.000173	0.00202	CcSEcCtD
Aminoglutethimide—Musculoskeletal discomfort—Estradiol—prostate cancer	0.000173	0.00201	CcSEcCtD
Aminoglutethimide—Nausea—Ethinyl Estradiol—prostate cancer	0.000173	0.00201	CcSEcCtD
Aminoglutethimide—Tachycardia—Mitoxantrone—prostate cancer	0.000173	0.00201	CcSEcCtD
Aminoglutethimide—Pruritus—Goserelin—prostate cancer	0.00017	0.00197	CcSEcCtD
Aminoglutethimide—Somnolence—Estradiol—prostate cancer	0.000169	0.00197	CcSEcCtD
Aminoglutethimide—Anorexia—Mitoxantrone—prostate cancer	0.000169	0.00196	CcSEcCtD
Aminoglutethimide—Pruritus—Conjugated Estrogens—prostate cancer	0.000168	0.00195	CcSEcCtD
Aminoglutethimide—Anaemia—Etoposide—prostate cancer	0.000167	0.00194	CcSEcCtD
Aminoglutethimide—Hypotension—Mitoxantrone—prostate cancer	0.000165	0.00193	CcSEcCtD
Aminoglutethimide—Decreased appetite—Estradiol—prostate cancer	0.000165	0.00192	CcSEcCtD
Aminoglutethimide—Leukopenia—Etoposide—prostate cancer	0.000162	0.00188	CcSEcCtD
Aminoglutethimide—Musculoskeletal discomfort—Mitoxantrone—prostate cancer	0.000161	0.00188	CcSEcCtD
Aminoglutethimide—Dizziness—Goserelin—prostate cancer	0.000158	0.00184	CcSEcCtD
Aminoglutethimide—Somnolence—Mitoxantrone—prostate cancer	0.000157	0.00183	CcSEcCtD
Aminoglutethimide—Dizziness—Conjugated Estrogens—prostate cancer	0.000157	0.00183	CcSEcCtD
Aminoglutethimide—Decreased appetite—Mitoxantrone—prostate cancer	0.000154	0.00179	CcSEcCtD
Aminoglutethimide—Vomiting—Goserelin—prostate cancer	0.000152	0.00177	CcSEcCtD
Aminoglutethimide—Rash—Goserelin—prostate cancer	0.000151	0.00176	CcSEcCtD
Aminoglutethimide—Dermatitis—Goserelin—prostate cancer	0.000151	0.00176	CcSEcCtD
Aminoglutethimide—Vomiting—Conjugated Estrogens—prostate cancer	0.000151	0.00176	CcSEcCtD
Aminoglutethimide—Urticaria—Estradiol—prostate cancer	0.000151	0.00176	CcSEcCtD
Aminoglutethimide—Body temperature increased—Estradiol—prostate cancer	0.00015	0.00175	CcSEcCtD
Aminoglutethimide—Headache—Goserelin—prostate cancer	0.00015	0.00175	CcSEcCtD
Aminoglutethimide—Rash—Conjugated Estrogens—prostate cancer	0.00015	0.00174	CcSEcCtD
Aminoglutethimide—Dermatitis—Conjugated Estrogens—prostate cancer	0.00015	0.00174	CcSEcCtD
Aminoglutethimide—Headache—Conjugated Estrogens—prostate cancer	0.000149	0.00173	CcSEcCtD
Aminoglutethimide—Tachycardia—Etoposide—prostate cancer	0.000144	0.00167	CcSEcCtD
Aminoglutethimide—Nausea—Goserelin—prostate cancer	0.000142	0.00166	CcSEcCtD
Aminoglutethimide—Nausea—Conjugated Estrogens—prostate cancer	0.000141	0.00164	CcSEcCtD
Aminoglutethimide—Urticaria—Mitoxantrone—prostate cancer	0.000141	0.00164	CcSEcCtD
Aminoglutethimide—Anorexia—Etoposide—prostate cancer	0.00014	0.00163	CcSEcCtD
Aminoglutethimide—Hypersensitivity—Estradiol—prostate cancer	0.00014	0.00163	CcSEcCtD
Aminoglutethimide—Body temperature increased—Mitoxantrone—prostate cancer	0.00014	0.00163	CcSEcCtD
Aminoglutethimide—Anaemia—Docetaxel—prostate cancer	0.000139	0.00161	CcSEcCtD
Aminoglutethimide—Pancytopenia—Epirubicin—prostate cancer	0.000138	0.0016	CcSEcCtD
Aminoglutethimide—Hypotension—Etoposide—prostate cancer	0.000138	0.0016	CcSEcCtD
Aminoglutethimide—Neutropenia—Epirubicin—prostate cancer	0.000136	0.00158	CcSEcCtD
Aminoglutethimide—Pruritus—Estradiol—prostate cancer	0.000134	0.00156	CcSEcCtD
Aminoglutethimide—Leukopenia—Docetaxel—prostate cancer	0.000134	0.00156	CcSEcCtD
Aminoglutethimide—Anaemia—Capecitabine—prostate cancer	0.000134	0.00156	CcSEcCtD
Aminoglutethimide—Somnolence—Etoposide—prostate cancer	0.000131	0.00152	CcSEcCtD
Aminoglutethimide—Hypersensitivity—Mitoxantrone—prostate cancer	0.00013	0.00152	CcSEcCtD
Aminoglutethimide—Leukopenia—Capecitabine—prostate cancer	0.00013	0.00151	CcSEcCtD
Aminoglutethimide—Drowsiness—Epirubicin—prostate cancer	0.000129	0.00151	CcSEcCtD
Aminoglutethimide—Decreased appetite—Etoposide—prostate cancer	0.000128	0.00149	CcSEcCtD
Aminoglutethimide—Myalgia—Docetaxel—prostate cancer	0.000128	0.00149	CcSEcCtD
Aminoglutethimide—Pancytopenia—Doxorubicin—prostate cancer	0.000128	0.00148	CcSEcCtD
Aminoglutethimide—Dizziness—Estradiol—prostate cancer	0.000126	0.00146	CcSEcCtD
Aminoglutethimide—Neutropenia—Doxorubicin—prostate cancer	0.000126	0.00146	CcSEcCtD
Aminoglutethimide—Myalgia—Capecitabine—prostate cancer	0.000124	0.00144	CcSEcCtD
Aminoglutethimide—Vomiting—Estradiol—prostate cancer	0.000121	0.00141	CcSEcCtD
Aminoglutethimide—Agranulocytosis—Epirubicin—prostate cancer	0.000121	0.00141	CcSEcCtD
Aminoglutethimide—Rash—Estradiol—prostate cancer	0.00012	0.00139	CcSEcCtD
Aminoglutethimide—Drowsiness—Doxorubicin—prostate cancer	0.00012	0.00139	CcSEcCtD
Aminoglutethimide—Dermatitis—Estradiol—prostate cancer	0.00012	0.00139	CcSEcCtD
Aminoglutethimide—Anaemia—Prednisone—prostate cancer	0.00012	0.00139	CcSEcCtD
Aminoglutethimide—Tachycardia—Docetaxel—prostate cancer	0.000119	0.00139	CcSEcCtD
Aminoglutethimide—Headache—Estradiol—prostate cancer	0.000119	0.00139	CcSEcCtD
Aminoglutethimide—Urticaria—Etoposide—prostate cancer	0.000117	0.00136	CcSEcCtD
Aminoglutethimide—Anorexia—Docetaxel—prostate cancer	0.000117	0.00136	CcSEcCtD
Aminoglutethimide—Body temperature increased—Etoposide—prostate cancer	0.000116	0.00135	CcSEcCtD
Aminoglutethimide—Tachycardia—Capecitabine—prostate cancer	0.000116	0.00135	CcSEcCtD
Aminoglutethimide—Hypotension—Docetaxel—prostate cancer	0.000114	0.00133	CcSEcCtD
Aminoglutethimide—Anorexia—Capecitabine—prostate cancer	0.000113	0.00131	CcSEcCtD
Aminoglutethimide—Nausea—Estradiol—prostate cancer	0.000113	0.00131	CcSEcCtD
Aminoglutethimide—Vomiting—Mitoxantrone—prostate cancer	0.000113	0.00131	CcSEcCtD
Aminoglutethimide—Agranulocytosis—Doxorubicin—prostate cancer	0.000112	0.0013	CcSEcCtD
Aminoglutethimide—Rash—Mitoxantrone—prostate cancer	0.000112	0.0013	CcSEcCtD
Aminoglutethimide—Dermatitis—Mitoxantrone—prostate cancer	0.000112	0.0013	CcSEcCtD
Aminoglutethimide—Musculoskeletal discomfort—Docetaxel—prostate cancer	0.000111	0.0013	CcSEcCtD
Aminoglutethimide—Headache—Mitoxantrone—prostate cancer	0.000111	0.00129	CcSEcCtD
Aminoglutethimide—Hypotension—Capecitabine—prostate cancer	0.000111	0.00129	CcSEcCtD
Aminoglutethimide—Myalgia—Prednisone—prostate cancer	0.00011	0.00128	CcSEcCtD
Aminoglutethimide—Somnolence—Docetaxel—prostate cancer	0.000109	0.00127	CcSEcCtD
Aminoglutethimide—Hypersensitivity—Etoposide—prostate cancer	0.000108	0.00126	CcSEcCtD
Aminoglutethimide—Musculoskeletal discomfort—Capecitabine—prostate cancer	0.000108	0.00126	CcSEcCtD
Aminoglutethimide—Decreased appetite—Docetaxel—prostate cancer	0.000106	0.00124	CcSEcCtD
Aminoglutethimide—Nausea—Mitoxantrone—prostate cancer	0.000105	0.00122	CcSEcCtD
Aminoglutethimide—Pruritus—Etoposide—prostate cancer	0.000104	0.00121	CcSEcCtD
Aminoglutethimide—Tachycardia—Prednisone—prostate cancer	0.000103	0.0012	CcSEcCtD
Aminoglutethimide—Decreased appetite—Capecitabine—prostate cancer	0.000103	0.0012	CcSEcCtD
Aminoglutethimide—Anorexia—Prednisone—prostate cancer	0.000101	0.00117	CcSEcCtD
Aminoglutethimide—Dizziness—Etoposide—prostate cancer	9.74e-05	0.00113	CcSEcCtD
Aminoglutethimide—Body temperature increased—Docetaxel—prostate cancer	9.67e-05	0.00113	CcSEcCtD
Aminoglutethimide—Musculoskeletal discomfort—Prednisone—prostate cancer	9.62e-05	0.00112	CcSEcCtD
Aminoglutethimide—Urticaria—Capecitabine—prostate cancer	9.41e-05	0.0011	CcSEcCtD
Aminoglutethimide—Body temperature increased—Capecitabine—prostate cancer	9.37e-05	0.00109	CcSEcCtD
Aminoglutethimide—Vomiting—Etoposide—prostate cancer	9.36e-05	0.00109	CcSEcCtD
Aminoglutethimide—Anaemia—Epirubicin—prostate cancer	9.35e-05	0.00109	CcSEcCtD
Aminoglutethimide—Rash—Etoposide—prostate cancer	9.28e-05	0.00108	CcSEcCtD
Aminoglutethimide—Dermatitis—Etoposide—prostate cancer	9.28e-05	0.00108	CcSEcCtD
Aminoglutethimide—Headache—Etoposide—prostate cancer	9.23e-05	0.00107	CcSEcCtD
Aminoglutethimide—Decreased appetite—Prednisone—prostate cancer	9.17e-05	0.00107	CcSEcCtD
Aminoglutethimide—Leukopenia—Epirubicin—prostate cancer	9.05e-05	0.00105	CcSEcCtD
Aminoglutethimide—Hypersensitivity—Docetaxel—prostate cancer	9.02e-05	0.00105	CcSEcCtD
Aminoglutethimide—Nausea—Etoposide—prostate cancer	8.75e-05	0.00102	CcSEcCtD
Aminoglutethimide—Hypersensitivity—Capecitabine—prostate cancer	8.73e-05	0.00102	CcSEcCtD
Aminoglutethimide—Pruritus—Docetaxel—prostate cancer	8.66e-05	0.00101	CcSEcCtD
Aminoglutethimide—Anaemia—Doxorubicin—prostate cancer	8.65e-05	0.00101	CcSEcCtD
Aminoglutethimide—Myalgia—Epirubicin—prostate cancer	8.61e-05	0.001	CcSEcCtD
Aminoglutethimide—Urticaria—Prednisone—prostate cancer	8.38e-05	0.000976	CcSEcCtD
Aminoglutethimide—Pruritus—Capecitabine—prostate cancer	8.38e-05	0.000975	CcSEcCtD
Aminoglutethimide—Leukopenia—Doxorubicin—prostate cancer	8.38e-05	0.000975	CcSEcCtD
Aminoglutethimide—Body temperature increased—Prednisone—prostate cancer	8.34e-05	0.000971	CcSEcCtD
Aminoglutethimide—Dizziness—Docetaxel—prostate cancer	8.09e-05	0.000942	CcSEcCtD
Aminoglutethimide—Tachycardia—Epirubicin—prostate cancer	8.06e-05	0.000937	CcSEcCtD
Aminoglutethimide—Myalgia—Doxorubicin—prostate cancer	7.97e-05	0.000927	CcSEcCtD
Aminoglutethimide—Anorexia—Epirubicin—prostate cancer	7.87e-05	0.000916	CcSEcCtD
Aminoglutethimide—Dizziness—Capecitabine—prostate cancer	7.84e-05	0.000912	CcSEcCtD
Aminoglutethimide—Vomiting—Docetaxel—prostate cancer	7.78e-05	0.000905	CcSEcCtD
Aminoglutethimide—Hypersensitivity—Prednisone—prostate cancer	7.78e-05	0.000905	CcSEcCtD
Aminoglutethimide—Rash—Docetaxel—prostate cancer	7.72e-05	0.000898	CcSEcCtD
Aminoglutethimide—Hypotension—Epirubicin—prostate cancer	7.71e-05	0.000898	CcSEcCtD
Aminoglutethimide—Dermatitis—Docetaxel—prostate cancer	7.71e-05	0.000897	CcSEcCtD
Aminoglutethimide—Headache—Docetaxel—prostate cancer	7.67e-05	0.000892	CcSEcCtD
Aminoglutethimide—Vomiting—Capecitabine—prostate cancer	7.53e-05	0.000877	CcSEcCtD
Aminoglutethimide—Musculoskeletal discomfort—Epirubicin—prostate cancer	7.52e-05	0.000875	CcSEcCtD
Aminoglutethimide—Rash—Capecitabine—prostate cancer	7.47e-05	0.000869	CcSEcCtD
Aminoglutethimide—Pruritus—Prednisone—prostate cancer	7.47e-05	0.000869	CcSEcCtD
Aminoglutethimide—Dermatitis—Capecitabine—prostate cancer	7.46e-05	0.000869	CcSEcCtD
Aminoglutethimide—Tachycardia—Doxorubicin—prostate cancer	7.45e-05	0.000867	CcSEcCtD
Aminoglutethimide—Headache—Capecitabine—prostate cancer	7.42e-05	0.000864	CcSEcCtD
Aminoglutethimide—Somnolence—Epirubicin—prostate cancer	7.34e-05	0.000854	CcSEcCtD
Aminoglutethimide—Anorexia—Doxorubicin—prostate cancer	7.28e-05	0.000847	CcSEcCtD
Aminoglutethimide—Nausea—Docetaxel—prostate cancer	7.27e-05	0.000846	CcSEcCtD
Aminoglutethimide—Decreased appetite—Epirubicin—prostate cancer	7.18e-05	0.000835	CcSEcCtD
Aminoglutethimide—Hypotension—Doxorubicin—prostate cancer	7.14e-05	0.00083	CcSEcCtD
Aminoglutethimide—Nausea—Capecitabine—prostate cancer	7.04e-05	0.000819	CcSEcCtD
Aminoglutethimide—Dizziness—Prednisone—prostate cancer	6.98e-05	0.000812	CcSEcCtD
Aminoglutethimide—Musculoskeletal discomfort—Doxorubicin—prostate cancer	6.96e-05	0.00081	CcSEcCtD
Aminoglutethimide—Somnolence—Doxorubicin—prostate cancer	6.79e-05	0.00079	CcSEcCtD
Aminoglutethimide—Vomiting—Prednisone—prostate cancer	6.71e-05	0.000781	CcSEcCtD
Aminoglutethimide—Rash—Prednisone—prostate cancer	6.65e-05	0.000774	CcSEcCtD
Aminoglutethimide—Dermatitis—Prednisone—prostate cancer	6.65e-05	0.000774	CcSEcCtD
Aminoglutethimide—Decreased appetite—Doxorubicin—prostate cancer	6.64e-05	0.000773	CcSEcCtD
Aminoglutethimide—Headache—Prednisone—prostate cancer	6.61e-05	0.000769	CcSEcCtD
Aminoglutethimide—Urticaria—Epirubicin—prostate cancer	6.56e-05	0.000763	CcSEcCtD
Aminoglutethimide—Body temperature increased—Epirubicin—prostate cancer	6.53e-05	0.000759	CcSEcCtD
Aminoglutethimide—Nausea—Prednisone—prostate cancer	6.27e-05	0.00073	CcSEcCtD
Aminoglutethimide—Hypersensitivity—Epirubicin—prostate cancer	6.08e-05	0.000708	CcSEcCtD
Aminoglutethimide—Urticaria—Doxorubicin—prostate cancer	6.07e-05	0.000706	CcSEcCtD
Aminoglutethimide—Body temperature increased—Doxorubicin—prostate cancer	6.04e-05	0.000703	CcSEcCtD
Aminoglutethimide—Pruritus—Epirubicin—prostate cancer	5.84e-05	0.00068	CcSEcCtD
Aminoglutethimide—Hypersensitivity—Doxorubicin—prostate cancer	5.63e-05	0.000655	CcSEcCtD
Aminoglutethimide—Dizziness—Epirubicin—prostate cancer	5.46e-05	0.000635	CcSEcCtD
Aminoglutethimide—Pruritus—Doxorubicin—prostate cancer	5.4e-05	0.000629	CcSEcCtD
Aminoglutethimide—Vomiting—Epirubicin—prostate cancer	5.25e-05	0.000611	CcSEcCtD
Aminoglutethimide—Rash—Epirubicin—prostate cancer	5.2e-05	0.000606	CcSEcCtD
Aminoglutethimide—Dermatitis—Epirubicin—prostate cancer	5.2e-05	0.000605	CcSEcCtD
Aminoglutethimide—Headache—Epirubicin—prostate cancer	5.17e-05	0.000602	CcSEcCtD
Aminoglutethimide—Dizziness—Doxorubicin—prostate cancer	5.05e-05	0.000588	CcSEcCtD
Aminoglutethimide—Nausea—Epirubicin—prostate cancer	4.9e-05	0.000571	CcSEcCtD
Aminoglutethimide—Vomiting—Doxorubicin—prostate cancer	4.86e-05	0.000565	CcSEcCtD
Aminoglutethimide—Rash—Doxorubicin—prostate cancer	4.82e-05	0.00056	CcSEcCtD
Aminoglutethimide—Dermatitis—Doxorubicin—prostate cancer	4.81e-05	0.00056	CcSEcCtD
Aminoglutethimide—Headache—Doxorubicin—prostate cancer	4.78e-05	0.000557	CcSEcCtD
Aminoglutethimide—Nausea—Doxorubicin—prostate cancer	4.54e-05	0.000528	CcSEcCtD
Aminoglutethimide—CYP2C19—Metabolism—GSTA1—prostate cancer	6.24e-06	5.64e-05	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—PIK3CD—prostate cancer	6.19e-06	5.59e-05	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—NAT2—prostate cancer	6.17e-06	5.57e-05	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—GSTO1—prostate cancer	6.17e-06	5.57e-05	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—HSD3B2—prostate cancer	6.17e-06	5.57e-05	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—LPL—prostate cancer	6.16e-06	5.57e-05	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—PHGDH—prostate cancer	6.08e-06	5.49e-05	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—UMPS—prostate cancer	6.08e-06	5.49e-05	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—ARG2—prostate cancer	6.08e-06	5.49e-05	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism of lipids and lipoproteins—RXRA—prostate cancer	6.05e-06	5.47e-05	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—LDHB—prostate cancer	5.96e-06	5.39e-05	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—CYP1A1—prostate cancer	5.95e-06	5.38e-05	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	5.93e-06	5.36e-05	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—CYP2C18—prostate cancer	5.92e-06	5.34e-05	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—PLCB2—prostate cancer	5.92e-06	5.34e-05	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—LRP2—prostate cancer	5.92e-06	5.34e-05	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—ERCC2—prostate cancer	5.9e-06	5.33e-05	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—CYP3A5—prostate cancer	5.85e-06	5.29e-05	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—NOS3—prostate cancer	5.84e-06	5.28e-05	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—P4HB—prostate cancer	5.8e-06	5.24e-05	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—HPGD—prostate cancer	5.76e-06	5.2e-05	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—B4GALT4—prostate cancer	5.76e-06	5.2e-05	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—PDHA1—prostate cancer	5.65e-06	5.11e-05	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—UCP3—prostate cancer	5.65e-06	5.11e-05	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—GSTA3—prostate cancer	5.65e-06	5.11e-05	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—TCN2—prostate cancer	5.65e-06	5.11e-05	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—SLC22A1—prostate cancer	5.64e-06	5.1e-05	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	5.58e-06	5.04e-05	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—MTHFR—prostate cancer	5.55e-06	5.01e-05	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—SULT2A1—prostate cancer	5.5e-06	4.97e-05	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—PPARA—prostate cancer	5.44e-06	4.92e-05	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—TNFRSF21—prostate cancer	5.41e-06	4.89e-05	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—MED12—prostate cancer	5.41e-06	4.89e-05	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—SLC22A3—prostate cancer	5.39e-06	4.87e-05	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—HSD3B1—prostate cancer	5.39e-06	4.87e-05	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—PIK3CB—prostate cancer	5.39e-06	4.87e-05	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—GNG5—prostate cancer	5.37e-06	4.85e-05	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—PTGS2—prostate cancer	5.34e-06	4.83e-05	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—CYP7B1—prostate cancer	5.27e-06	4.76e-05	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—MTAP—prostate cancer	5.27e-06	4.76e-05	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism of lipids and lipoproteins—LPL—prostate cancer	5.23e-06	4.73e-05	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—TBXAS1—prostate cancer	5.17e-06	4.67e-05	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—GSTA4—prostate cancer	5.17e-06	4.67e-05	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—NCOA3—prostate cancer	5.17e-06	4.67e-05	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—SULT1E1—prostate cancer	5.13e-06	4.64e-05	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—SRD5A1—prostate cancer	5.13e-06	4.64e-05	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—CAV1—prostate cancer	5.12e-06	4.62e-05	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	5.08e-06	4.59e-05	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	5.05e-06	4.56e-05	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—GSTA2—prostate cancer	5.04e-06	4.55e-05	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—SULT1A1—prostate cancer	4.98e-06	4.5e-05	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—ABCG5—prostate cancer	4.98e-06	4.5e-05	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—HPGDS—prostate cancer	4.93e-06	4.45e-05	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—HSD17B3—prostate cancer	4.9e-06	4.42e-05	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—ACSL4—prostate cancer	4.9e-06	4.42e-05	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	4.89e-06	4.42e-05	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—GSTA1—prostate cancer	4.86e-06	4.39e-05	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—GSTO1—prostate cancer	4.81e-06	4.34e-05	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—HSD3B2—prostate cancer	4.81e-06	4.34e-05	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—NAT2—prostate cancer	4.81e-06	4.34e-05	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—ACHE—prostate cancer	4.78e-06	4.32e-05	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—GSTT1—prostate cancer	4.78e-06	4.32e-05	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—CYP2A6—prostate cancer	4.73e-06	4.27e-05	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	4.71e-06	4.25e-05	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—UMPS—prostate cancer	4.69e-06	4.24e-05	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—PHGDH—prostate cancer	4.69e-06	4.24e-05	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—ARG2—prostate cancer	4.69e-06	4.24e-05	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—PIK3CG—prostate cancer	4.66e-06	4.21e-05	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—PTEN—prostate cancer	4.66e-06	4.21e-05	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	4.62e-06	4.18e-05	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—CYP2C18—prostate cancer	4.61e-06	4.16e-05	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—LRP2—prostate cancer	4.61e-06	4.16e-05	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—PLCB2—prostate cancer	4.61e-06	4.16e-05	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—LDHB—prostate cancer	4.6e-06	4.16e-05	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—AKR1C3—prostate cancer	4.6e-06	4.15e-05	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—PRKACB—prostate cancer	4.58e-06	4.13e-05	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—CYP17A1—prostate cancer	4.53e-06	4.09e-05	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—P4HB—prostate cancer	4.52e-06	4.08e-05	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—CYP3A5—prostate cancer	4.52e-06	4.08e-05	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	4.47e-06	4.03e-05	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—EP300—prostate cancer	4.45e-06	4.01e-05	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—INS—prostate cancer	4.41e-06	3.99e-05	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—SLC22A1—prostate cancer	4.4e-06	3.97e-05	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—GSTA3—prostate cancer	4.36e-06	3.94e-05	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—TCN2—prostate cancer	4.36e-06	3.94e-05	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—PDHA1—prostate cancer	4.36e-06	3.94e-05	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—UCP3—prostate cancer	4.36e-06	3.94e-05	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	4.35e-06	3.93e-05	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—CREBBP—prostate cancer	4.32e-06	3.9e-05	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—NCOA2—prostate cancer	4.32e-06	3.9e-05	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—SULT2A1—prostate cancer	4.29e-06	3.87e-05	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—MED12—prostate cancer	4.22e-06	3.81e-05	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—GNG5—prostate cancer	4.18e-06	3.78e-05	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—HSD3B1—prostate cancer	4.16e-06	3.76e-05	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—SLC22A3—prostate cancer	4.16e-06	3.76e-05	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—SLC5A5—prostate cancer	4.12e-06	3.72e-05	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—PIK3CD—prostate cancer	4.1e-06	3.7e-05	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—NCOA3—prostate cancer	4.03e-06	3.64e-05	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—CYP2E1—prostate cancer	4.02e-06	3.63e-05	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—GSTA4—prostate cancer	3.99e-06	3.6e-05	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—TBXAS1—prostate cancer	3.99e-06	3.6e-05	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—NQO1—prostate cancer	3.98e-06	3.59e-05	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	3.96e-06	3.58e-05	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—TH—prostate cancer	3.92e-06	3.54e-05	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	3.89e-06	3.52e-05	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—GSTA2—prostate cancer	3.89e-06	3.51e-05	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—CYP3A4—prostate cancer	3.88e-06	3.5e-05	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—NOS3—prostate cancer	3.87e-06	3.5e-05	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	3.86e-06	3.48e-05	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—HPGDS—prostate cancer	3.84e-06	3.47e-05	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—ABCG5—prostate cancer	3.84e-06	3.47e-05	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—SULT1A1—prostate cancer	3.84e-06	3.47e-05	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—CYP2C19—prostate cancer	3.82e-06	3.45e-05	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—CYP1B1—prostate cancer	3.81e-06	3.44e-05	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—GSTA1—prostate cancer	3.75e-06	3.39e-05	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—ACHE—prostate cancer	3.73e-06	3.37e-05	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—GSTT1—prostate cancer	3.73e-06	3.37e-05	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—NAT2—prostate cancer	3.71e-06	3.35e-05	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—HSD3B2—prostate cancer	3.71e-06	3.35e-05	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—GSTO1—prostate cancer	3.71e-06	3.35e-05	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—GGT1—prostate cancer	3.69e-06	3.33e-05	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—CYP2A6—prostate cancer	3.69e-06	3.33e-05	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	3.67e-06	3.32e-05	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—NCOA1—prostate cancer	3.64e-06	3.28e-05	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—AKR1C3—prostate cancer	3.58e-06	3.24e-05	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—CYP19A1—prostate cancer	3.58e-06	3.24e-05	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—PIK3CB—prostate cancer	3.57e-06	3.23e-05	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—PRKACB—prostate cancer	3.57e-06	3.22e-05	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—PLCB2—prostate cancer	3.56e-06	3.21e-05	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—CYP2C18—prostate cancer	3.56e-06	3.21e-05	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—LRP2—prostate cancer	3.56e-06	3.21e-05	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—PTGS2—prostate cancer	3.54e-06	3.2e-05	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—CYP17A1—prostate cancer	3.53e-06	3.19e-05	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—P4HB—prostate cancer	3.49e-06	3.15e-05	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	3.48e-06	3.14e-05	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—RXRA—prostate cancer	3.46e-06	3.12e-05	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—SLC22A1—prostate cancer	3.39e-06	3.06e-05	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	3.36e-06	3.04e-05	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—NCOA2—prostate cancer	3.36e-06	3.04e-05	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—COMT—prostate cancer	3.33e-06	3.01e-05	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—GSTP1—prostate cancer	3.32e-06	3e-05	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—SULT2A1—prostate cancer	3.31e-06	2.99e-05	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—PIK3CA—prostate cancer	3.29e-06	2.97e-05	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—ITPR1—prostate cancer	3.26e-06	2.95e-05	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—MED12—prostate cancer	3.25e-06	2.94e-05	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—GNG5—prostate cancer	3.23e-06	2.92e-05	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism of lipids and lipoproteins—EP300—prostate cancer	3.21e-06	2.9e-05	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—SLC5A5—prostate cancer	3.21e-06	2.9e-05	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—CYP2E1—prostate cancer	3.13e-06	2.83e-05	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—NCOA3—prostate cancer	3.11e-06	2.81e-05	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—NQO1—prostate cancer	3.1e-06	2.8e-05	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—PTEN—prostate cancer	3.09e-06	2.79e-05	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—TYMS—prostate cancer	3.08e-06	2.78e-05	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—TH—prostate cancer	3.05e-06	2.76e-05	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—GSTM1—prostate cancer	3.05e-06	2.75e-05	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	3.03e-06	2.74e-05	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—CYP3A4—prostate cancer	3.02e-06	2.73e-05	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	3.01e-06	2.71e-05	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—LPL—prostate cancer	2.99e-06	2.7e-05	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—CYP1B1—prostate cancer	2.97e-06	2.68e-05	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—HPGDS—prostate cancer	2.97e-06	2.68e-05	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—CYP2C19—prostate cancer	2.95e-06	2.66e-05	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—EP300—prostate cancer	2.94e-06	2.66e-05	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—CYP1A1—prostate cancer	2.89e-06	2.61e-05	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—GSTT1—prostate cancer	2.88e-06	2.6e-05	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—ACHE—prostate cancer	2.88e-06	2.6e-05	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—GGT1—prostate cancer	2.88e-06	2.6e-05	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—ERCC2—prostate cancer	2.87e-06	2.59e-05	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—CYP2A6—prostate cancer	2.84e-06	2.57e-05	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—NCOA1—prostate cancer	2.83e-06	2.56e-05	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—CYP19A1—prostate cancer	2.79e-06	2.52e-05	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—AKR1C3—prostate cancer	2.77e-06	2.5e-05	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—PRKACB—prostate cancer	2.75e-06	2.49e-05	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—CYP17A1—prostate cancer	2.72e-06	2.46e-05	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—RXRA—prostate cancer	2.7e-06	2.43e-05	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—MTHFR—prostate cancer	2.69e-06	2.43e-05	CbGpPWpGaD
Aminoglutethimide—CYP11A1—Metabolism—AKT1—prostate cancer	2.69e-06	2.43e-05	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—PPARA—prostate cancer	2.64e-06	2.39e-05	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	2.62e-06	2.37e-05	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—COMT—prostate cancer	2.6e-06	2.34e-05	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—NCOA2—prostate cancer	2.6e-06	2.34e-05	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—GSTP1—prostate cancer	2.58e-06	2.33e-05	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—ITPR1—prostate cancer	2.54e-06	2.3e-05	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism of lipids and lipoproteins—EP300—prostate cancer	2.5e-06	2.26e-05	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—CAV1—prostate cancer	2.48e-06	2.24e-05	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—SLC5A5—prostate cancer	2.48e-06	2.24e-05	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—CYP2E1—prostate cancer	2.42e-06	2.18e-05	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—TYMS—prostate cancer	2.4e-06	2.17e-05	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—NQO1—prostate cancer	2.39e-06	2.16e-05	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—GSTM1—prostate cancer	2.37e-06	2.14e-05	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	2.37e-06	2.14e-05	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—TH—prostate cancer	2.36e-06	2.13e-05	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—LPL—prostate cancer	2.33e-06	2.1e-05	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—CYP1B1—prostate cancer	2.29e-06	2.07e-05	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—PIK3CG—prostate cancer	2.26e-06	2.04e-05	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—CYP1A1—prostate cancer	2.25e-06	2.03e-05	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—ERCC2—prostate cancer	2.23e-06	2.02e-05	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—GGT1—prostate cancer	2.22e-06	2.01e-05	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—NCOA1—prostate cancer	2.19e-06	1.98e-05	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—PIK3CA—prostate cancer	2.18e-06	1.97e-05	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—CYP19A1—prostate cancer	2.16e-06	1.95e-05	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—INS—prostate cancer	2.14e-06	1.93e-05	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—MTHFR—prostate cancer	2.1e-06	1.9e-05	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—CREBBP—prostate cancer	2.1e-06	1.89e-05	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—RXRA—prostate cancer	2.08e-06	1.88e-05	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—PPARA—prostate cancer	2.06e-06	1.86e-05	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—COMT—prostate cancer	2e-06	1.81e-05	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—GSTP1—prostate cancer	1.99e-06	1.8e-05	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—PIK3CD—prostate cancer	1.99e-06	1.8e-05	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—ITPR1—prostate cancer	1.96e-06	1.77e-05	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—CAV1—prostate cancer	1.94e-06	1.75e-05	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—NOS3—prostate cancer	1.88e-06	1.7e-05	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—TYMS—prostate cancer	1.85e-06	1.67e-05	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.85e-06	1.67e-05	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—GSTM1—prostate cancer	1.83e-06	1.66e-05	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—LPL—prostate cancer	1.8e-06	1.62e-05	CbGpPWpGaD
Aminoglutethimide—CYP19A1—Metabolism—AKT1—prostate cancer	1.78e-06	1.61e-05	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—PIK3CG—prostate cancer	1.76e-06	1.59e-05	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—CYP1A1—prostate cancer	1.74e-06	1.57e-05	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—PIK3CB—prostate cancer	1.73e-06	1.57e-05	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—ERCC2—prostate cancer	1.72e-06	1.56e-05	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—PTGS2—prostate cancer	1.72e-06	1.55e-05	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—INS—prostate cancer	1.67e-06	1.51e-05	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—CREBBP—prostate cancer	1.63e-06	1.48e-05	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—MTHFR—prostate cancer	1.62e-06	1.46e-05	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—PPARA—prostate cancer	1.59e-06	1.44e-05	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—PIK3CD—prostate cancer	1.55e-06	1.4e-05	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—PTEN—prostate cancer	1.5e-06	1.35e-05	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—CAV1—prostate cancer	1.49e-06	1.35e-05	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—NOS3—prostate cancer	1.46e-06	1.32e-05	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—EP300—prostate cancer	1.43e-06	1.29e-05	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—PIK3CG—prostate cancer	1.36e-06	1.23e-05	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—PIK3CB—prostate cancer	1.35e-06	1.22e-05	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—PTGS2—prostate cancer	1.34e-06	1.21e-05	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—INS—prostate cancer	1.29e-06	1.16e-05	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—CREBBP—prostate cancer	1.26e-06	1.14e-05	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—PIK3CD—prostate cancer	1.2e-06	1.08e-05	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—PTEN—prostate cancer	1.17e-06	1.05e-05	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—NOS3—prostate cancer	1.13e-06	1.02e-05	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—EP300—prostate cancer	1.11e-06	1.01e-05	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—PIK3CA—prostate cancer	1.06e-06	9.55e-06	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—PIK3CB—prostate cancer	1.04e-06	9.42e-06	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—PTGS2—prostate cancer	1.03e-06	9.33e-06	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—PTEN—prostate cancer	9.01e-07	8.14e-06	CbGpPWpGaD
Aminoglutethimide—CYP2C19—Metabolism—AKT1—prostate cancer	8.64e-07	7.8e-06	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—EP300—prostate cancer	8.59e-07	7.76e-06	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—PIK3CA—prostate cancer	8.24e-07	7.44e-06	CbGpPWpGaD
Aminoglutethimide—CYP1A2—Metabolism—AKT1—prostate cancer	6.73e-07	6.08e-06	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—PIK3CA—prostate cancer	6.36e-07	5.74e-06	CbGpPWpGaD
Aminoglutethimide—CYP3A4—Metabolism—AKT1—prostate cancer	5.19e-07	4.69e-06	CbGpPWpGaD
